Affinity-Asset-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "NUVL",
  "AXSM",
  "EWTX",
  "TRVI",
  "CNTA",
  "ALKS",
  "INSM",
  "NAMS",
  "MDGL",
  "ALNY",
  "ABVX",
  "OLMA",
  "CATX",
  "MIRM",
  "THRD",
  "TVTX",
  "TRML",
  "NRIX",
  "MLYS",
  "KYMR",
  "ADGM",
  "AKBA",
  "ALLK",
  "AVTX",
  "AVR",
  "ESTA",
  "GERN",
  "GALT",
  "SYRE",
  "APGE",
  "AUTL",
  "NBIX",
  null,
  "LXEO",
  "MNPR",
  null,
  "NXTC",
  "NKTX",
  "OVID",
  "OKUR",
  "PRQR",
  "QTTB",
  "RPTX",
  "STRO",
  null,
  null,
  "RZLT",
  "EXEL",
  "TEVA",
  "IBRX",
  "ZURA",
  null,
  "SPY",
  null,
  null,
  "AMGN",
  null,
  null,
  null,
  "PTGX",
  "MBX",
  null,
  "SLNO",
  "ACLX",
  "QURE",
  "OMER",
  "ETNB",
  "WVE",
  "ROIV",
  null,
  "CNTX",
  "ERAS",
  "INZY",
  "VRNA",
  "VKTX",
  "VRDN",
  "XENE",
  "ORKA",
  "VERA",
  "IMVT",
  "PCVX",
  null,
  "BDTX",
  "BBIO",
  "CMPX",
  "CORT",
  "CRNX",
  "CGEM",
  "IWM",
  "MGTX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 91
Total Value: 976714470
Accession Number: 0001999371-25-006074
Form Type: 13F-HR
CIK: affinity-asset-advisors
Manager Name: Affinity-Asset-Advisors

Data Enrichment

86% identified

78 identified13 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

91 positions • $976.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 4 of 5

Sort by:

008064107

Shares:800.0K

Value:$2.0M

% of Portfolio:0.2% ($2.0M/$976.7M)

Cullinan Therapeutics, Inc.

CGEM|230031106

Shares:263.8K

Value:$2.0M

% of Portfolio:0.2% ($2.0M/$976.7M)

28658R106

Shares:1.5M

Value:$1.8M

% of Portfolio:0.2% ($1.8M/$976.7M)

OnKure Therapeutics, Inc.

OKUR|68277Q105

Shares:394.2K

Value:$1.7M

% of Portfolio:0.2% ($1.7M/$976.7M)

NewAmsterdam Pharma Co N.V.

NAMS|N62509109

Shares:75.0K

Value:$1.5M

% of Portfolio:0.2% ($1.5M/$976.7M)

Tourmaline Bio, Inc.

TRML|89157D105

Shares:100.0K

Value:$1.5M

% of Portfolio:0.2% ($1.5M/$976.7M)

Roivant Sciences Ltd.

ROIV|G76279101

Shares:150.0K

Value:$1.5M

% of Portfolio:0.2% ($1.5M/$976.7M)

Nkarta, Inc.

NKTX|65487U108

Shares:800.0K

Value:$1.5M

% of Portfolio:0.2% ($1.5M/$976.7M)

Anteris Technologies Global Corp.

AVR|03675P102

Shares:390.0K

Value:$1.4M

% of Portfolio:0.1% ($1.4M/$976.7M)

MBX Biosciences, Inc.

MBX|55287L101

Shares:175.0K

Value:$1.3M

% of Portfolio:0.1% ($1.3M/$976.7M)

Third Harmonic Bio, Inc.

THRD|88427A107

Shares:370.0K

Value:$1.3M

% of Portfolio:0.1% ($1.3M/$976.7M)

89bio, Inc.

ETNB|282559103

Shares:175.0K

Value:$1.3M

% of Portfolio:0.1% ($1.3M/$976.7M)

Abivax S.A.

ABVX|00370M103

Shares:200.0K

Value:$1.3M

% of Portfolio:0.1% ($1.3M/$976.7M)

Olema Pharmaceuticals, Inc.

OLMA|68062P106

Shares:325.0K

Value:$1.2M

% of Portfolio:0.1% ($1.2M/$976.7M)

NextCure, Inc.

NXTC|65343E108

Shares:2.3M

Value:$1.1M

% of Portfolio:0.1% ($1.1M/$976.7M)

MeiraGTx Holdings plc

MGTX|G59665102

Shares:150.0K

Value:$1.0M

% of Portfolio:0.1% ($1.0M/$976.7M)

Vaxcyte, Inc.

PCVX|92243G108

Shares:25.0K

Value:$944.0K

% of Portfolio:0.1% ($944.0K/$976.7M)

Viking Therapeutics, Inc.

VKTX|92686J106

Shares:25.0K

Value:$603.8K

% of Portfolio:0.1% ($603.8K/$976.7M)

SUTRO BIOPHARMA, INC.

STRO|869367102

Shares:752.7K

Value:$489.7K

% of Portfolio:0.1% ($489.7K/$976.7M)

Context Therapeutics Inc.

CNTX|21077P108

Shares:660.6K

Value:$404.3K

% of Portfolio:0.0% ($404.3K/$976.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
(cusip008064107)✕	800.0K	QoQ 0.00% (-0) YoY NEW(+800.0K)	All Managers (Combined)	$2.0M	0.2% ($2.0M/$976.7M)	QoQ -5.28% (-$112.0K) YoY NEW(+$2.0M)
Cullinan Therapeutics, Inc.(CGEMcusip230031106)	263.8K	QoQ 0.00% (-0) YoY +2.02% (-5.2K)	All Managers (Combined)	$2.0M	0.2% ($2.0M/$976.7M)	QoQ -37.84% (-$1.2M) YoY -54.67% (-$2.4M)
(cusip28658R106)✕	1.5M	QoQ +200.00% (+1.0M) YoY NEW(+1.5M)	All Managers (Combined)	$1.8M	0.2% ($1.8M/$976.7M)	QoQ +103.33% (+$930.0K) YoY NEW(+$1.8M)
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	394.2K	QoQ +173.41% (+250.0K) YoY NEW(+394.2K)	All Managers (Combined)	$1.7M	0.2% ($1.7M/$976.7M)	QoQ +36.70% (+$455.1K) YoY NEW(+$1.7M)
NewAmsterdam Pharma Co N.V.(NAMScusipN62509109)	75.0K	QoQ -82.35% (-350.0K) YoY -73.79% (-211.2K)	All Managers (Combined)	$1.5M	0.2% ($1.5M/$976.7M)	QoQ -85.94% (-$9.4M) YoY -77.31% (-$5.2M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	100.0K	QoQ NEW(+100.0K) YoY +100.00% (+50.0K)	All Managers (Combined)	$1.5M	0.2% ($1.5M/$976.7M)	QoQ NEW(+$1.5M) YoY +32.83% (+$376.0K)
Roivant Sciences Ltd.(ROIVcusipG76279101)	150.0K	QoQ NEW(+150.0K) YoY -70.00% (-350.0K)	All Managers (Combined)	$1.5M	0.2% ($1.5M/$976.7M)	QoQ NEW(+$1.5M) YoY -71.28% (-$3.8M)
Nkarta, Inc.(NKTXcusip65487U108)	800.0K	QoQ 0.00% (-0) YoY NEW(+800.0K)	All Managers (Combined)	$1.5M	0.2% ($1.5M/$976.7M)	QoQ -26.10% (-$520.0K) YoY NEW(+$1.5M)
Anteris Technologies Global Corp.(AVRcusip03675P102)	390.0K	QoQ +30.00% (-90.0K) YoY NEW(+390.0K)	All Managers (Combined)	$1.4M	0.1% ($1.4M/$976.7M)	QoQ -15.19% (-$254.4K) YoY NEW(+$1.4M)
MBX Biosciences, Inc.(MBXcusip55287L101)	175.0K	QoQ NEW(+175.0K) YoY NEW(+175.0K)	All Managers (Combined)	$1.3M	0.1% ($1.3M/$976.7M)	QoQ NEW(+$1.3M) YoY NEW(+$1.3M)
Third Harmonic Bio, Inc.(THRDcusip88427A107)	370.0K	QoQ NEW(+370.0K) YoY NEW(+370.0K)	All Managers (Combined)	$1.3M	0.1% ($1.3M/$976.7M)	QoQ NEW(+$1.3M) YoY NEW(+$1.3M)
89bio, Inc.(ETNBcusip282559103)	175.0K	QoQ NEW(+175.0K) YoY NEW(+175.0K)	All Managers (Combined)	$1.3M	0.1% ($1.3M/$976.7M)	QoQ NEW(+$1.3M) YoY NEW(+$1.3M)
Abivax S.A.(ABVXcusip00370M103)	200.0K	QoQ NEW(+200.0K) YoY NEW(+200.0K)	All Managers (Combined)	$1.3M	0.1% ($1.3M/$976.7M)	QoQ NEW(+$1.3M) YoY NEW(+$1.3M)
Olema Pharmaceuticals, Inc.(OLMAcusip68062P106)	325.0K	QoQ NEW(+325.0K) YoY NEW(+325.0K)	All Managers (Combined)	$1.2M	0.1% ($1.2M/$976.7M)	QoQ NEW(+$1.2M) YoY NEW(+$1.2M)
NextCure, Inc.(NXTCcusip65343E108)	2.3M	QoQ 0.00% (-0) YoY +69.42% (-943.6K)	All Managers (Combined)	$1.1M	0.1% ($1.1M/$976.7M)	QoQ -37.70% (-$669.4K) YoY -63.50% (-$1.9M)
MeiraGTx Holdings plc(MGTXcusipG59665102)	150.0K	QoQ NEW(+150.0K) YoY NEW(+150.0K)	All Managers (Combined)	$1.0M	0.1% ($1.0M/$976.7M)	QoQ NEW(+$1.0M) YoY NEW(+$1.0M)
Vaxcyte, Inc.(PCVXcusip92243G108)	25.0K	QoQ 0.00% (-0) YoY -68.75% (-55.0K)	All Managers (Combined)	$944.0K	0.1% ($944.0K/$976.7M)	QoQ -53.87% (-$1.1M) YoY -82.72% (-$4.5M)
Viking Therapeutics, Inc.(VKTXcusip92686J106)	25.0K	QoQ NEW(+25.0K) YoY -50.00% (-25.0K)	All Managers (Combined)	$603.8K	0.1% ($603.8K/$976.7M)	QoQ NEW(+$603.8K) YoY -85.27% (-$3.5M)
SUTRO BIOPHARMA, INC.(STROcusip869367102)	752.7K	QoQ NEW(+752.7K) YoY NEW(+752.7K)	All Managers (Combined)	$489.7K	0.1% ($489.7K/$976.7M)	QoQ NEW(+$489.7K) YoY NEW(+$489.7K)
Context Therapeutics Inc.(CNTXcusip21077P108)	660.6K	QoQ -34.93% (-354.8K) YoY +100.89% (-331.8K)	All Managers (Combined)	$404.3K	0.0% ($404.3K/$976.7M)	QoQ -62.07% (-$661.8K) YoY -10.90% (-$49.5K)